MainboardNSELISTED

Symbiotec Pharmalab IPO

₹938 – ₹938 · Issue Size ₹1,757 Cr

IPO Overview

StatusListed
Price Band₹938 – ₹938
Issue Size₹1,757 Cr
Lot Size15 shares
Min Investment₹14,820
Face Value₹2
Issue Structure
Fresh Issue₹150 Cr
Offer for Sale₹1,62,65,181 Cr
Total Size₹1,757 Cr

IPO Timeline

Open Date24 Aug 2026
Close Date27 Aug 2026
Allotment28 Aug 2026
Refund31 Aug 2026
Credit to Demat31 Aug 2026
Listing Date1 Sept 2026

Listing Performance

Issue Price₹938 – ₹938
Listing Price—
Listing Gain—

Management & Promoters

Anil SatwaniKashish SatwaniSushil Satwani and Satwani Holdings LLP

Shareholding Pattern

Promoters
Anil SatwaniKashish SatwaniSushil Satwani and Satwani Holdings LLP

About

Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica

ExchangeNSE
Issue Typemainboard
Face Value₹2 per share

rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.